Literature DB >> 27169758

From solution to in-cell study of the chemical reactivity of acid sensitive functional groups: a rational approach towards improved cleavable linkers for biospecific endosomal release.

Sylvain A Jacques1, Geoffray Leriche, Michel Mosser, Marc Nothisen, Christian D Muller, Jean-Serge Remy, Alain Wagner.   

Abstract

pH-Sensitive linkers designed to undergo selective hydrolysis at acidic pH compared to physiological pH can be used for the selective release of therapeutics at their site of action. In this paper, the hydrolytic cleavage of a wide variety of molecular structures that have been reported for their use in pH-sensitive delivery systems was examined. A wide variety of hydrolytic stability profiles were found among the panel of tested chemical functionalities. Even within a structural family, a slight modification of the substitution pattern has an unsuspected outcome on the hydrolysis stability. This work led us to establish a first classification of these groups based on their reactivities at pH 5.5 and their relative hydrolysis at pH 5.5 vs. pH 7.4. From this classification, four representative chemical functions were selected and studied in-vitro. The results revealed that only the most reactive functions underwent significant lysosomal cleavage, according to flow cytometry measurements. These last results question the acid-based mechanism of action of known drug release systems and advocate for the importance of an in-depth structure-reactivity study, using a tailored methodology, for the rational design and development of bio-responsive linkers.

Mesh:

Substances:

Year:  2016        PMID: 27169758     DOI: 10.1039/c6ob00846a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  1 in total

1.  Bicyclo[6.1.0]nonyne carboxylic acid for the production of stable molecular probes.

Authors:  Tony Rady; Michel Mosser; Marc Nothisen; Stephane Erb; Igor Dovgan; Sarah Cianférani; Alain Wagner; Guilhem Chaubet
Journal:  RSC Adv       Date:  2021-11-17       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.